Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)	Series B Preferred Stock	Series C Preferred Stock	Common Stock	Additional Paid In Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2020			$ 8,514	$ 7,034,502	$ (5,762,321)	$ 1,280,695
Balance (in Shares) at Dec. 31, 2020			85,141,956
Series C preferred stock issued for cash, net of offering cost				3,794,102		3,794,102
Series C preferred stock issued for cash, net of offering cost (in Shares)		4,276
Deemed dividend upon issuance of preferred stock				1,403,997	(1,403,997)
Common stock warrants granted for services				83,728		83,728
Net loss					(930,702)	(930,702)
Balance at Mar. 31, 2021			$ 8,514	12,316,329	(8,097,020)	4,227,823
Balance (in Shares) at Mar. 31, 2021		4,276	85,141,956
Common stock issued for conversion of Series C preferred stock			$ 1,350	(1,350)
Common stock issued for conversion of Series C preferred stock (in Shares)		(4,049)	13,495,014
Net loss					(461,990)	(461,990)
Balance at Jun. 30, 2021			$ 9,864	12,314,979	(8,559,010)	3,765,833
Balance (in Shares) at Jun. 30, 2021		227	98,636,970
Balance at Dec. 31, 2021			$ 9,864	12,314,979	(3,262,577)	9,062,266
Balance (in Shares) at Dec. 31, 2021		227	98,636,970
Stock options issued as stock based compensation				45,009		45,009
Common stock issued for conversion of Series C preferred stock			$ 76	(76)
Common stock issued for conversion of Series C preferred stock (in Shares)		(227)	758,334
Net loss					(604,072)	(604,072)
Balance at Mar. 31, 2022			$ 9,940	12,359,912	(3,866,649)	8,503,203
Balance (in Shares) at Mar. 31, 2022			99,395,304
Stock options issued as stock based compensation				15,112		15,112
Amortization of prepaid stock-based compensation				14,124		14,124
Net loss					(658,402)	(658,402)
Balance at Jun. 30, 2022			$ 9,940	$ 12,389,148	$ (4,525,051)	$ 7,874,037
Balance (in Shares) at Jun. 30, 2022			99,395,304